P27815 (PDE4A_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 126.
History...
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: cAMP-specific 3',5'-cyclic phosphodiesterase 4A EC=3.1.4.17 Alternative name(s): DPDE2 PDE46 | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 886 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Hydrolyzes the second messenger cAMP, which is a key regulator of many important physiological processes. Ref.13 Ref.18 |
| Catalytic activity | Adenosine 3',5'-cyclic phosphate + H2O = adenosine 5'-phosphate. |
| Cofactor | Binds 2 divalent metal cations per subunit. Site 1 may preferentially bind zinc ions, while site 2 has a preference for magnesium and/or manganese ions. Ref.18 |
| Enzyme regulation | Isoform 1, isoform 2, isoform 6 and isoform 7 are inhibited by rolipram and cilomilast. Isoform 1, isoform 2 and isoform 6 are inhibited by 4-[(3-butoxy-4-methoxyphenyl)-methyl]-2-imidazolidinone (Ro 20-1724), roflumilast and denbufylline. Ref.5 Ref.6 Ref.7 |
| Pathway | Purine metabolism; 3',5'-cyclic AMP degradation; AMP from 3',5'-cyclic AMP: step 1/1. |
| Subunit structure | Isoform 1 interacts with LYN. Isoform 2 and isoform 6 interact weakly with LYN. Isoform 1, isoform 2 and isoform 6 interact with ARRB2. Ref.5 Ref.6 |
| Subcellular location | Isoform 1: Cytoplasm › perinuclear region Ref.5 Ref.6 Ref.7. Isoform 2: Cytoplasm › perinuclear region Ref.5 Ref.6 Ref.7. Cell projection › ruffle membrane Ref.5 Ref.6 Ref.7. Isoform 4: Membrane; Peripheral membrane protein. Note: Isoform 4 has propensity for association with membranes. Ref.5 Ref.6 Ref.7 Isoform 6: Cytoplasm › perinuclear region Ref.5 Ref.6 Ref.7. Isoform 7: Cytoplasm. Membrane. Note: Predominantly cytoplasmic. Ref.5 Ref.6 Ref.7 |
| Tissue specificity | Isoform 1 is widely expressed. Isoform 2 is abundant in liver, stomach, testis, thyroid and adrenal glands. It is also found in placenta, kidney, pancreas, ovary, uterus, skin, monocytes, mast cells, macrophages, as well as in bronchial smooth muscle. Isoform 6 is expressed at high levels in the heart and small intestine. It is also found in the brain, kidney, spleen, colon, salivary gland, ovary and peripheral blood lymphocytes. Isoform 7 is expressed predominantly in skeletal muscle and brain and at lower levels in the testis. Isoform 7 is expressed in the brain. Found in specific neuronal subpopulations in cortex, spinal cord and cerebellum (at protein level). Ref.5 Ref.6 Ref.7 |
| Post-translational modification | Phosphorylation by MAPKAPK2 its activation through PKA phosphorylation By similarity. Phosphorylated at Ser-686 and Ser-688 when expressed in S.frugiperda cells. Isoform 2 and isoform 7 are activated by phosphorylation at Ser-119 and Ser-123 respectively by PKA. Ref.6 Ref.7 Ref.13 Proteolytically cleaved by caspase-3. Ref.6 |
| Sequence similarities | Belongs to the cyclic nucleotide phosphodiesterase family. PDE4 subfamily. |
| Biophysicochemical properties | Kinetic parameters: KM=4.0 µM for cAMP (isoform 2) Ref.5 Ref.6 KM=3 µM for cAMP (isoform 6) |
Ontologies
Alternative products
| This entry describes 7 isoforms produced by alternative splicing. [Align] [Select] Note: Additional isoforms seem to exist. | ||||||
| Isoform 1 (identifier: P27815-1) Also known as: PDE4A4; PDE4A4B; PDE46; This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: P27815-2) Also known as: TM3; PDE4A11; The sequence of this isoform differs from the canonical sequence as follows: 1-107: MEPPTVPSER...GGAGGGSSRR → MARPRGLGRI...LGRQAWAGAG | ||||||
| Isoform 3 (identifier: P27815-3) Also known as: PDE4A7; PDE4A6; The sequence of this isoform differs from the canonical sequence as follows: 1-209: MEPPTVPSER...NVPVPSNKRS → MCPFPVTTV | ||||||
| Isoform 4 (identifier: P27815-4) Also known as: PDE4A1; RD1; The sequence of this isoform differs from the canonical sequence as follows: 1-261: MEPPTVPSER...RSVSEMASHK → MPLVDFFCETCSKPWLVGWWDQ | ||||||
| Isoform 5 (identifier: P27815-5) Also known as: PDE4A8A; 2EL; The sequence of this isoform differs from the canonical sequence as follows: 1-367: MEPPTVPSER...KTDQEELLAQ → MVLPSDQGFKLLGNVLQGPEPYRLLTSGLRLHQ 644-657: GFIDYIVHPLWETW → QARGIDGRAQGGFY 658-886: Missing. | ||||||
| Note: May be produced at very low levels due to a premature stop codon in the mRNA, leading to nonsense-mediated mRNA decay. Probably represents a non-functional splice isoform. | ||||||
| Isoform 6 (identifier: P27815-6) Also known as: PDE4A10; The sequence of this isoform differs from the canonical sequence as follows: 1-107: MEPPTVPSER...GGAGGGSSRR → MRSGAAPRAR...RRHPPGRSVS | ||||||
| Isoform 7 (identifier: P27815-7) Also known as: PDE4A8; The sequence of this isoform differs from the canonical sequence as follows: 1-107: MEPPTVPSER...GGAGGGSSRR → MKRSRSALSV...ISITRAENDS |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Molecule processing | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 886 | 886 | cAMP-specific 3',5'-cyclic phosphodiesterase 4A | PRO_0000198806 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Regions | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Nucleotide binding | 433 – 437 | 5 | cAMP By similarity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Region | 330 – 723 | 394 | Catalytic | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sites | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Active site | 433 | 1 | Proton donor By similarity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Metal binding | 437 | 1 | Divalent metal cation 1 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Metal binding | 473 | 1 | Divalent metal cation 1 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Metal binding | 474 | 1 | Divalent metal cation 1 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Metal binding | 474 | 1 | Divalent metal cation 2 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Metal binding | 591 | 1 | Divalent metal cation 1 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Binding site | 474 | 1 | cAMP By similarity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Binding site | 591 | 1 | cAMP By similarity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Binding site | 642 | 1 | cAMP By similarity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Site | 69 – 70 | 2 | Cleavage; by caspase-3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Site | 594 | 1 | Binds AMP, but not cAMP By similarity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Amino acid modifications | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 152 | 1 | Phosphoserine; by MAPKAPK2 By similarity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 165 | 1 | Phosphoserine Ref.16 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 686 | 1 | Phosphoserine Probable | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Modified residue | 688 | 1 | Phosphoserine Probable | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Cross-link | 358 | Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO) Ref.17 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Natural variations | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 1 – 367 | 367 | MEPPT…ELLAQ → MVLPSDQGFKLLGNVLQGPE PYRLLTSGLRLHQ in isoform 5. | VSP_004559 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 1 – 261 | 261 | MEPPT…MASHK → MPLVDFFCETCSKPWLVGWW DQ in isoform 4. | VSP_004558 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 1 – 209 | 209 | MEPPT…SNKRS → MCPFPVTTV in isoform 3. | VSP_004557 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 1 – 107 | 107 | MEPPT…GSSRR → MARPRGLGRIPELQLVAFPV AVAAEDEAFLPEPLAPRAPR RPRSPPSSPVFFASPSPTFR RRLRLLRSCQDLGRQAWAGA G in isoform 2. | VSP_004556 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 1 – 107 | 107 | MEPPT…GSSRR → MRSGAAPRARPRPPALALPP TGPESLTHFPFSDEDTRRHP PGRSVS in isoform 6. | VSP_038185 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 1 – 107 | 107 | MEPPT…GSSRR → MKRSRSALSVAGTGDERSRE TPESDRANMLGADLRRPRRR LSSGPGLGWAQPEPSDPGVP LPPRPTTLPLLIPPRISITR AENDS in isoform 7. | VSP_038186 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 644 – 657 | 14 | GFIDY…LWETW → QARGIDGRAQGGFY in isoform 5. | VSP_004560 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 658 – 886 | 229 | Missing in isoform 5. | VSP_004561 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 736 | 1 | A → E. Ref.3 Ref.11 Corresponds to variant rs1051738 [ dbSNP | Ensembl ]. | VAR_059544 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 808 | 1 | H → Y. Corresponds to variant rs2230190 [ dbSNP | Ensembl ]. | VAR_059545 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Secondary structure | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Helix Strand Turn | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 362 – 368 | 7 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 369 – 371 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 379 – 385 | 7 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 386 – 388 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 390 – 401 | 12 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 404 – 407 | 4 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 412 – 424 | 13 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 430 – 434 | 5 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 435 – 449 | 15 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 452 – 454 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 455 – 457 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 460 – 472 | 13 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 473 – 476 | 4 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 482 – 487 | 6 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 491 – 495 | 5 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 496 – 498 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 501 – 512 | 12 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 513 – 515 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 521 – 524 | 4 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 527 – 542 | 16 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 546 – 548 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 549 – 561 | 13 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 567 – 569 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 576 – 591 | 16 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 594 – 596 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 599 – 622 | 24 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 633 – 635 | 3 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 638 – 648 | 11 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 650 – 660 | 11 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 661 – 665 | 5 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 666 – 682 | 17 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "A family of human phosphodiesterases homologous to the dunce learning and memory gene product of Drosophila melanogaster are potential targets for antidepressant drugs." Bolger G., Michaeli T., Martins T., St John T., Steiner B., Rodgers L., Riggs M., Wigler M., Ferguson K. Mol. Cell. Biol. 13:6558-6571(1993) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). |
| [2] | "Molecular cloning and expression, in both COS-1 cells and S. cerevisiae, of a human cytosolic type-IVA, cyclic AMP specific phosphodiesterase (hPDE-IVA-h6.1)." Sullivan M., Egerton M., Shakur Y., Marquardsen A., Houslay M.D. Cell. Signal. 6:793-812(1994) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3). |
| [3] | "Molecular cloning of a novel splice variant of human type IVA (PDE-IVA) cyclic AMP phosphodiesterase and localization of the gene to the p13.2-q12 region of human chromosome 19." Horton Y.M., Sullivan M., Houslay M.D. Biochem. J. 308:683-691(1995) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 3 AND 5), VARIANT GLU-736. |
| [4] | "Identification and characterization of the human homologue of the short PDE4A cAMP-specific phosphodiesterase 4A variant RD1 (PDE4A1) by analysis of the human HSPDE4A gene locus located at chromosome 19p13.2." Sullivan M., Rena G., Begg F., Gordon L., Olsen A.S., Houslay M.D. Biochem. J. 333:693-703(1998) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORMS 1; 2; 3; 4 AND 5). Tissue: Brain. |
| [5] | "Molecular cloning, genomic positioning, promoter identification, and characterization of the novel cyclic AMP-specific phosphodiesterase PDE4A10." Rena G., Begg F., Ross A., MacKenzie C., McPhee I., Campbell L., Huston E., Sullivan M., Houslay M.D. Mol. Pharmacol. 59:996-1011(2001) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 6), SUBCELLULAR LOCATION, BIOPHYSICOCHEMICAL PROPERTIES, ENZYME REGULATION, TISSUE SPECIFICITY, INTERACTION WITH LYN. Tissue: Brain. |
| [6] | "Identification and characterization of PDE4A11, a novel, widely expressed long isoform encoded by the human PDE4A cAMP phosphodiesterase gene." Wallace D.A., Johnston L.A., Huston E., Macmaster D., Houslay T.M., Cheung Y.-F., Campbell L., Millen J.E., Smith R.A., Gall I., Knowles R.G., Sullivan M., Houslay M.D. Mol. Pharmacol. 67:1920-1934(2005) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), SUBCELLULAR LOCATION, TISSUE SPECIFICITY, ENZYME REGULATION, BIOPHYSICOCHEMICAL PROPERTIES, PHOSPHORYLATION AT SER-119 (ISOFORM 2), CLEAVAGE BY CASPASE-3 (ISOFORM 1), INTERACTION WITH LYN AND ARRB2. |
| [7] | "Human PDE4A8, a novel brain-expressed PDE4 cAMP-specific phosphodiesterase that has undergone rapid evolutionary change." Mackenzie K.F., Topping E.C., Bugaj-Gaweda B., Deng C., Cheung Y.-F., Olsen A.E., Stockard C.R., High Mitchell L., Baillie G.S., Grizzle W.E., De Vivo M., Houslay M.D., Wang D., Bolger G.B. Biochem. J. 411:361-369(2008) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 7), SUBCELLULAR LOCATION, ENZYME REGULATION, TISSUE SPECIFICITY, PHOSPHORYLATION AT SER-123 (ISOFORM 7). |
| [8] | "The DNA sequence and biology of human chromosome 19." Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J., Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M., Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E., Caenepeel S., Carrano A.V. Lucas S.M.Nature 428:529-535(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [9] | Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [10] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4). Tissue: Brain. |
| [11] | "Cloning and expression of cDNA for a human low-Km, rolipram-sensitive cyclic AMP phosphodiesterase." Livi G.P., Kmetz P., McHale M.M., Cieslinski L.B., Sathe G.M., Taylor D.P., Davis R.L., Torphy T.J., Balcarek J.M. Mol. Cell. Biol. 10:2678-2686(1990) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 112-886, VARIANT GLU-736. Tissue: Monocyte. |
| [12] | McLaughlin M.M. Submitted (JAN-1991) to the EMBL/GenBank/DDBJ databases Cited for: SEQUENCE REVISION. |
| [13] | "Purification and characterization of the human pde4a catalytic domain (pde4a(330-723)) expressed in sf9 cells." Lario P.I., Bobechko B., Bateman K., Kelly J., Vrielink A., Huang Z. Arch. Biochem. Biophys. 394:54-60(2001) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, PHOSPHORYLATION AT SER-686 AND SER-688, MASS SPECTROMETRY. |
| [14] | "An unappreciated role for RNA surveillance." Hillman R.T., Green R.E., Brenner S.E. Genome Biol. 5:R8.1-R8.16(2004) [PubMed] [Europe PMC] [Abstract] Cited for: SPLICE ISOFORM(S) THAT ARE POTENTIAL NMD TARGET(S). |
| [15] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. Tissue: Cervix carcinoma. |
| [16] | "Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions." Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K., Rodionov V., Han D.K. Sci. Signal. 2:RA46-RA46(2009) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-165, MASS SPECTROMETRY. Tissue: Leukemic T-cell. |
| [17] | "Selective SUMO modification of cAMP-specific phosphodiesterase-4D5 (PDE4D5) regulates the functional consequences of phosphorylation by PKA and ERK." Li X., Vadrevu S., Dunlop A., Day J., Advant N., Troeger J., Klussmann E., Jaffrey E., Hay R.T., Adams D.R., Houslay M.D., Baillie G.S. Biochem. J. 428:55-65(2010) [PubMed] [Europe PMC] [Abstract] Cited for: SUMOYLATION AT LYS-358 BY PIAS4. |
| [18] | "Structures of the four subfamilies of phosphodiesterase-4 provide insight into the selectivity of their inhibitors." Wang H., Peng M.-S., Chen Y., Geng J., Robinson H., Houslay M.D., Cai J., Ke H. Biochem. J. 408:193-201(2007) [PubMed] [Europe PMC] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (2.10 ANGSTROMS) OF 351-683 IN COMPLEX WITH METAL IONS AND THE INHIBITOR NVP, FUNCTION, COFACTOR. |
| [19] | "Crystal structure of human PDE4a with 4-(3-butoxy-4-methoxyphenyl)methyl-2-imidazolidone." Cheng R.K.Y., Crawley L., Barker J., Wood M., Felicetti B., Whittaker M. Submitted (JUL-2009) to the PDB data bank Cited for: X-RAY CRYSTALLOGRAPHY (2.25 ANGSTROMS) OF 351-683 IN COMPLEX WITH METAL IONS AND INHIBITOR. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | L20965 mRNA. Translation: AAA03588.1. S75213 mRNA. Translation: AAB33798.1. U18087 mRNA. Translation: AAC50458.1. U18088 mRNA. Translation: AAA98540.1. AF069491 AF069490 Genomic DNA. Translation: AAC35012.1.AF069491, AF069489, AF069490 Genomic DNA. Translation: AAC35013.1. AF069491, AF069489, AF069490 Genomic DNA. Translation: AAC35014.1. AF069491 AF069490 Genomic DNA. Translation: AAC35015.1.U68532 mRNA. Translation: AAC63832.1. U97584 mRNA. Translation: AAC25679.1. AF073745 mRNA. Translation: AAD34217.2. AY618547 mRNA. Translation: AAU82096.1. AY593872 mRNA. Translation: AAT00628.1. AC011548 Genomic DNA. No translation available. AC011529 Genomic DNA. No translation available. AC011461 Genomic DNA. No translation available. CH471106 Genomic DNA. Translation: EAW84104.1. CH471106 Genomic DNA. Translation: EAW84105.1. CH471106 Genomic DNA. Translation: EAW84108.1. BC019864 mRNA. Translation: AAH19864.1. BC038234 mRNA. Translation: AAH38234.1. M37744 mRNA. Translation: AAA69697.1. | ||||||||||||||||||||||||
| IPI | IPI00006232. IPI00020973. IPI00171460. IPI00220048. IPI00220052. IPI00940499. IPI00945522. | ||||||||||||||||||||||||
| PIR | A54442. S55348. | ||||||||||||||||||||||||
| RefSeq | NP_001104777.1. NM_001111307.1. NP_001104778.1. NM_001111308.1. NP_001104779.1. NM_001111309.1. NP_001230050.1. NM_001243121.1. NP_006193.1. NM_006202.2. | ||||||||||||||||||||||||
| UniGene | Hs.89901. | ||||||||||||||||||||||||
3D structure databases | |||||||||||||||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||||||||||||||
| ProteinModelPortal | P27815. | ||||||||||||||||||||||||
| ModBase | Search... | ||||||||||||||||||||||||
PTM databases | |||||||||||||||||||||||||
| PhosphoSite | P27815. | ||||||||||||||||||||||||
Polymorphism databases | |||||||||||||||||||||||||
| DMDM | 116242706. | ||||||||||||||||||||||||
Proteomic databases | |||||||||||||||||||||||||
| PaxDb | P27815. | ||||||||||||||||||||||||
| PRIDE | P27815. | ||||||||||||||||||||||||
Protocols and materials databases | |||||||||||||||||||||||||
| DNASU | 5141. | ||||||||||||||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||||||||||||||
Genome annotation databases | |||||||||||||||||||||||||
| Ensembl | ENST00000293683; ENSP00000293683; ENSG00000065989. ENST00000344979; ENSP00000341007; ENSG00000065989. ENST00000352831; ENSP00000270474; ENSG00000065989. ENST00000380702; ENSP00000370078; ENSG00000065989. ENST00000440014; ENSP00000394754; ENSG00000065989. ENST00000592685; ENSP00000468507; ENSG00000065989. | ||||||||||||||||||||||||
| GeneID | 5141. | ||||||||||||||||||||||||
| KEGG | hsa:5141. | ||||||||||||||||||||||||
| UCSC | uc002moj.2. human. uc002mok.2. human. uc002mol.2. human. uc002mom.2. human. uc002moo.2. human. uc021uow.1. human. | ||||||||||||||||||||||||
Organism-specific databases | |||||||||||||||||||||||||
| CTD | 5141. | ||||||||||||||||||||||||
| GeneCards | GC19P010527. | ||||||||||||||||||||||||
| HGNC | HGNC:8780. PDE4A. | ||||||||||||||||||||||||
| HPA | CAB017632. | ||||||||||||||||||||||||
| MIM | 600126. gene. | ||||||||||||||||||||||||
| neXtProt | NX_P27815. | ||||||||||||||||||||||||
| PharmGKB | PA33128. | ||||||||||||||||||||||||
| GenAtlas | Search... | ||||||||||||||||||||||||
Phylogenomic databases | |||||||||||||||||||||||||
| eggNOG | NOG122287. | ||||||||||||||||||||||||
| HOVERGEN | HBG108239. | ||||||||||||||||||||||||
| InParanoid | P27815. | ||||||||||||||||||||||||
| KO | K01120. | ||||||||||||||||||||||||
| OMA | HIPVDTM. | ||||||||||||||||||||||||
| OrthoDB | EOG402WRM. | ||||||||||||||||||||||||
| PhylomeDB | P27815. | ||||||||||||||||||||||||
Enzyme and pathway databases | |||||||||||||||||||||||||
| Reactome | REACT_111102. Signal Transduction. | ||||||||||||||||||||||||
| UniPathway | UPA00762; UER00747. | ||||||||||||||||||||||||
Gene expression databases | |||||||||||||||||||||||||
| ArrayExpress | P27815. | ||||||||||||||||||||||||
| Bgee | P27815. | ||||||||||||||||||||||||
| CleanEx | HS_PDE4A. | ||||||||||||||||||||||||
| Genevestigator | P27815. | ||||||||||||||||||||||||
| GermOnline | ENSG00000065989. Homo sapiens. | ||||||||||||||||||||||||
Family and domain databases | |||||||||||||||||||||||||
| Gene3D | 1.10.1300.10. 1 hit. | ||||||||||||||||||||||||
| InterPro | IPR003607. HD/PDEase_dom. IPR023088. PDEase. IPR002073. PDEase_catalytic_dom. IPR023174. PDEase_CS. [Graphical view] | ||||||||||||||||||||||||
| Pfam | PF00233. PDEase_I. 1 hit. [Graphical view] | ||||||||||||||||||||||||
| PRINTS | PR00387. PDIESTERASE1. | ||||||||||||||||||||||||
| SMART | SM00471. HDc. 1 hit. [Graphical view] | ||||||||||||||||||||||||
| PROSITE | PS00126. PDEASE_I. 1 hit. [Graphical view] | ||||||||||||||||||||||||
| ProtoNet | Search... | ||||||||||||||||||||||||
Other | |||||||||||||||||||||||||
| BindingDB | P27815. | ||||||||||||||||||||||||
| ChEMBL | CHEMBL254. | ||||||||||||||||||||||||
| ChiTaRS | PDE4A. human. | ||||||||||||||||||||||||
| DrugBank | DB01166. Cilostazol. DB00975. Dipyridamole. DB00651. Dyphylline. DB00824. Enprofylline. DB01088. Iloprost. DB00235. Milrinone. DB00806. Pentoxifylline. DB00692. Phentolamine. DB00820. Tadalafil. DB00277. Theophylline. | ||||||||||||||||||||||||
| EvolutionaryTrace | P27815. | ||||||||||||||||||||||||
| GenomeRNAi | 5141. | ||||||||||||||||||||||||
| NextBio | 19824. | ||||||||||||||||||||||||
| SOURCE | Search... | ||||||||||||||||||||||||
Entry information
| Entry name | PDE4A_HUMAN | ||||||||
| Accession | Primary (citable) accession number: P27815 Secondary accession number(s): O75522 Q9H3H2 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 19 Human chromosome 19: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PATHWAY comments Index of metabolic and biosynthesis pathways |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with
